Earlier Alzheimer's detection in minutes
Novoic (novoic.com) scores 72 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, SaaS brands, in the 33rd percentile of 21279 Healthcare brands.
Novoic is a healthcare technology company that develops AI-enabled, speech-based cognitive testing tools designed to detect subtle cognitive impairment and Alzheimer's-related neuropathology in approximately 10 minutes. Its mission is to scale access to early Alzheimer's detection for anyone, anywhere, addressing the fact that less than 1% of people currently receive such testing. Novoic targets healthcare institutions, clinicians, researchers, and medical centers focused on neurology, as well as underserved communities lacking diagnostic access, positioning itself as a leader in real-world-ready AI diagnostics for early-stage Alzheimer's detection.
| Brand Name | Novoic |
|---|---|
| Domain | novoic.com |
| Industry | Healthcare, Technology |
| Main Competitors | Linus Health (70/100), Neurotrack (80/100), Cogstate (80/100), Winterlight Labs (69/100), Aural Analytics, Canary Speech (73/100) |
Moz Domain Authority 25/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Novoic website" (Meta description too short (2 words). No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Nginx.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram, GitHub; no detected presence on LinkedIn, YouTube - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked November 2026.
When asked "What is Novoic?", Claude could identify the brand as of November 2026. Novoic is a UK-based health-tech company that develops AI-powered speech analysis tools to detect and monitor early signs of cognitive decline and neurological conditions like Alzheimer's disease, using voice biomarkers extracted from short speech samples. Best known for Using AI and speech analysis to detect early signs of Alzheimer's and other neurological conditions via voice biomarkers.
When asked "Best brands similar to Novoic?", Claude would recommend Novoic as of November 2026. It's a notable player in the digital biomarker and AI-driven neurology diagnostics space, so I'd mention it if someone asked about innovative Alzheimer's detection or voice-based health tech startups.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Novoic's main competitors in Healthcare: Linus Health (70/100), Neurotrack (80/100), Cogstate (80/100), Winterlight Labs (69/100), Canary Speech (73/100).
Sources: Brand Analyzer scan
Novoic has low AI-search visibility, scoring 22/100 on Brand Analyzer's AI visibility composite (visibility 15, trust 22, recommendation 34). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Novoic official site
Novoic scores 34/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Novoic official site
Novoic offers an AI-enabled, speech-based cognitive testing service that analyzes speech patterns to detect subtle cognitive impairment and markers of Alzheimer's neuropathology. The test is designed to be completed in about 10 minutes, making it a scalable diagnostic tool intended for use by healthcare institutions, clinicians, and researchers working in neurology and early-stage Alzheimer's detection.
Sources: Novoic official site
Novoic is a healthcare technology company specializing in AI-enabled, speech-based cognitive testing for the early detection of Alzheimer's disease. It operates in the healthcare, technology, and SaaS categories, providing diagnostic tools aimed at expanding access to cognitive assessment beyond traditional clinical settings.
Sources: Novoic official site
Novoic develops AI-powered speech analysis technology that detects subtle cognitive impairment and signs of Alzheimer's neuropathology. Its testing process takes approximately 10 minutes and is designed to be scalable, enabling healthcare institutions, clinicians, and researchers to screen for early-stage Alzheimer's disease more broadly than current diagnostic methods allow, including in underserved communities with limited access to specialist care.
Sources: Novoic official site
Novoic can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Novoic official site
Novoic's target users include healthcare institutions, clinicians, researchers, and medical centers focused on neurology and early-stage Alzheimer's detection. The company also aims to serve underserved communities that currently lack access to diagnostic care for cognitive decline and Alzheimer's disease.
Sources: Novoic official site
Novoic is known for its speech-based, AI-driven cognitive testing approach to detecting early signs of Alzheimer's disease. The company emphasizes making a rapid, roughly 10-minute test accessible to a much wider population than the less than 1% currently served by traditional diagnostic methods, particularly within underserved communities and medical institutions.
Sources: Novoic official site
Novoic scores 22/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Novoic has a weak AI-visibility profile at 22/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (34/100) and its weakest is visibility (15/100). It benefits from a Wikidata knowledge-graph entry and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 25/100 and thin schema.org structured data. In a live check, Claude could already identify Novoic from memory (November 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Novoic: Nova IVF Fertility (72/100), Northwestern Medical Center (72/100), Noyo (72/100), National Qigong Association (72/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.